Once weekly subcutaneous injection of TransCon hGH
TransCon hGH CT-301
Phase 3 small_molecule completed
Quick answer
Once weekly subcutaneous injection of TransCon hGH for Growth Hormone Deficiency, Pediatric is a Phase 3 program (small_molecule) at Ascendis Pharma Endocrinology Division A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ascendis Pharma Endocrinology Division A/S
- Indication
- Growth Hormone Deficiency, Pediatric
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed